Integra LifeSciences Receives FDA 510(k) Clearance for Titan Reverse Shoulder System

The FDA awarded 510(k) clearance to Plainsboro, N.J.-based Integra LifeSciences' Integra Titan Reverse Shoulder System. A limited U.S. market release will start in the third quarter, and the global launch will start upon CE Mark clearance in Europe.

The Titan system is designed to simplify the conversion of a primary total shoulder to a reverse shoulder without the need to remove a stem well-fixed to a patient's bone.

More Articles on Devices:
The Orthopedic Institute in Sioux Falls Adopts coflex Interlaminar Stabilization for Spinal Stenosis
Dr. Richard Reitman Implants First TaperFill Total Hip Replacement by DJO Global
Study: Motion Preservation, Non-Fusion Advances Will Become Key Players as Spine Device Market Grows to $8.7B by 2018